| GlaxoSmithKline AG - Zejula 100 mg, Filmtabletten | | 68652 | | 01 | | Zejula 100 mg | | Filmtabletten | | L01XK02 | | Niraparib | | 20.01.2023 | | |
| | Composition | | niraparibum 100 mg ut niraparibi tosilas monohydricus, cellulosum microcristallinum, lactosum monohydricum 34.66 mg, povidonum K 30, crospovidonum, silica colloidalis hydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, E 172 (nigrum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Niraparibum | 100 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Niraparibum | 100 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Nigrum) | | | | Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 171 | | color. | | E 172 | | color. | | Lactose Monohydrate | 34.66 mg | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Povidonum K | 30 | | | Pro Compresso Obducto | | | | Silica Colloidalis Hydrica | | | | Talcum | | |
| |
| |
|
